asa glp-1 agonist guidelines 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f GLP-1 receptor agonists and next-generation

Bisphosphonates (such as alendronic acid) remain first-line treatment for osteoporosis and can be safely co-prescribed with GLP-1 receptor agonists

Its a win for employers and employees, especially as demand for these meds explodes

1 Given the differences within the drug class, switching from one GLP1RA to another may be beneficial and may delay the need to intensify therapy, thus avoiding an increase in treatment burden

New treatment options expand choice and help more people find care that fits their lives, their goals and where they are in their journey whether theyre just starting to explore treatment or looking for a different long-term approach, noted Nadglowski

Abstract Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D)